Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial
暂无分享，去创建一个
D. Sahani | J. Meyerhardt | Douglas B. Evans | J. Berlin | M. Moore | R. Wolff | P. Pisters | V. Deshpande | M. Posner | N. Merchant | J. Misdraji | F. Ou | L. Goff | H. Kindler | Q. Shi | E. Tamm | E. O’Reilly | A. Wei | E. Newman | X. Carrero